✦ LIBER ✦

A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation

✍ Scribed by K. T. Smerud; S. Dolgos; I. C. Olsen; A. Åsberg; S. Sagedal; A. V. Reisæter; K. Midtvedt; P. Pfeffer; T. Ueland; K. Godang; J. Bollerslev; A. Hartmann

Book ID: 117963603
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 667 KB
Volume: 12
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2012.04233.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ibandronate Prevents Bone Loss and Reduc

Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial

✍ Astrid Fahrleitner-Pammer; Jutta Claudia Piswanger-Soelkner; Thomas Rudolf Piebe 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 611 KB

The effect of soy isoflavone on bone min

The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study

✍ T. Y. Tai; K. S. Tsai; S. T. Tu; J. S. Wu; C. I. Chang; C. L. Chen; N. S. Shaw; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 209 KB

The effect on bone mass and bone markers

The effect on bone mass and bone markers of different doses of ibandronate — A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis. A 1-year, randomized, double-blind, placebo-controlled dose-finding study

✍ P. Ravn; B. Clemmesen; B. J. Riis; C. Christiansen 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 43 KB

The effect on bone mass and bone markers

The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study

✍ Ravn, P.; Clemmesen, B.; Riis, B.J.; C., Christiansen 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 907 KB

The effect on bone mass and bone markers

The effect on bone mass and bone markers of different doses of ibandronate - a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis. a 1-year, randomized, double-blind, placebo-controlled dose-finding study

✍ Ravn, Pernille; Clemmesen, Biørg; Riis, Bente Juel; Christiansen, Claus 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A Double-Blind Placebo-Controlled Study

A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease

✍ Abitbol, Vered; Briot, Karine; Roux, Christian; Roy, Carine; Seksik, Philippe; C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 309 KB